Myelofibrosis: Difference between revisions
| Line 33: | Line 33: | ||
==[[Myelofibrosis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Myelofibrosis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Myelofibrosis | ==[[Myelofibrosis risk factors|Risk Factors]]== | ||
==[[Myelofibrosis natural history|Natural History, Complications and Prognosis]]== | ==[[Myelofibrosis natural history|Natural History, Complications and Prognosis]]== | ||
Revision as of 20:21, 17 September 2012
For patient information, click here
Template:DiseaseDisorder infobox
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Assmann's Disease; Heuck-Assmann disease; agnogenic myeloid metaplasia; chronic idiopathic myelofibrosis; primary myelofibrosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies